Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» pirtobrutinib
pirtobrutinib
Eli Lilly Was Hoping for 5 Big Drug Launches This Year. Here's How It Has Done Thus Far.
Motley Fool
Fri, 11/10/23 - 12:19 pm
Eli Lilly
donanemab
tirzepatide
mirikizumab
lebrikizumab
pirtobrutinib
ASH 2022 – pirtobrutinib leads the post-Imbruvica charge
EP Vantage
Wed, 12/14/22 - 10:18 am
ASH 2022
Eli Lilly
BeiGene
Nurix Therapeutics
Brukinsa
pirtobrutinib
NX-2127
Eli Lilly’s 2023 guidance: Up to 4 new drugs on the way
Medical Marketing and Media
Tue, 12/13/22 - 11:54 pm
Eli Lilly
donanemab
mirikizumab
lebrikizumab
pirtobrutinib
ASH: Eli Lilly pads novel BTK's case amid FDA review. But AbbVie-J&J, BeiGene and AZ need not worry
Fierce Biotech
Mon, 12/12/22 - 10:45 pm
Eli Lilly
ASH 2022
pirtobrutinib